- Home
- SERA vs FBIO Comparison
SERA vs FBIO Comparison
Compare SERA & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SERA
- FBIO
- Stock Information
- Founded
- SERA 2008
- FBIO 2006
- Country
- SERA United States
- FBIO United States
- Employees
- SERA N/A
- FBIO N/A
- Industry
- SERA Precision Instruments
- FBIO Biotechnology: Pharmaceutical Preparations
- Sector
- SERA Health Care
- FBIO Health Care
- Exchange
- SERA Nasdaq
- FBIO Nasdaq
- Market Cap
- SERA 90.6M
- FBIO 88.7M
- IPO Year
- SERA 2021
- FBIO N/A
- Fundamental
- Price
- SERA $3.25
- FBIO $2.71
- Analyst Decision
- SERA
- FBIO Strong Buy
- Analyst Count
- SERA 0
- FBIO 2
- Target Price
- SERA N/A
- FBIO $16.50
- AVG Volume (30 Days)
- SERA 44.5K
- FBIO 1.5M
- Earning Date
- SERA 11-05-2025
- FBIO 11-13-2025
- Dividend Yield
- SERA N/A
- FBIO N/A
- EPS Growth
- SERA N/A
- FBIO N/A
- EPS
- SERA N/A
- FBIO N/A
- Revenue
- SERA $108,000.00
- FBIO $59,301,000.00
- Revenue This Year
- SERA $217.92
- FBIO $31.85
- Revenue Next Year
- SERA $479.25
- FBIO $44.43
- P/E Ratio
- SERA N/A
- FBIO N/A
- Revenue Growth
- SERA 0.94
- FBIO N/A
- 52 Week Low
- SERA $1.37
- FBIO $1.33
- 52 Week High
- SERA $9.13
- FBIO $4.20
- Technical
- Relative Strength Index (RSI)
- SERA 57.38
- FBIO 40.90
- Support Level
- SERA $3.11
- FBIO $2.59
- Resistance Level
- SERA $3.40
- FBIO $2.90
- Average True Range (ATR)
- SERA 0.18
- FBIO 0.23
- MACD
- SERA 0.00
- FBIO -0.12
- Stochastic Oscillator
- SERA 81.09
- FBIO 8.32
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.